Financhill
Back

CRISPR Therapeutics AG Stock Price Chart

Introducing The Great $2 AI Moonshot

Open your free presentation now
Sell
21

CRSP
CRISPR Therapeutics AG

Last Price:
45.40
Seasonality Move:
9.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Free ChatGPT Investor Guide: 5 Stocks to Buy ASAP

Access the report now.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

CRISPR Therapeutics AG Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 46.04 Sell
20-day SMA: 48.36 Sell
50-day SMA: 50.26 Sell
200-day SMA: 51.82 Sell
8-day EMA: 46.4 Sell
20-day EMA: 47.76 Sell
50-day EMA: 50.12 Sell
200-day EMA: 54.09 Sell

CRISPR Therapeutics AG Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.38 Sell
Relative Strength Index (14 RSI): 36.72 Sell
Chaikin Money Flow: -584551 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.67 - 50.77) Sell
Bollinger Bands (100): (49.15 - 61.61) Sell

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for CRISPR Therapeutics AG Stock

Is CRISPR Therapeutics AG Stock a Buy?

CRSP Technical Analysis vs Fundamental Analysis

Sell
21
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy or a Sell?

CRISPR Therapeutics AG Stock Info

Market Cap:
3.6B
Price in USD:
45.39
Share Volume:
725.51K

CRISPR Therapeutics AG 52-Week Range

52-Week High:
72.00
52-Week Low:
38.94
Sell
21
CRISPR Therapeutics AG (CRSP) is a Sell

CRISPR Therapeutics AG Share Price Forecast

Is CRISPR Therapeutics AG Stock a Buy?

Fundamental Analysis of CRISPR Therapeutics AG

Is CRISPR Therapeutics AG a good investment?

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.11 per share, and a decrease next year of $2.20 per share.

Technical Analysis of CRISPR Therapeutics AG

Should I short CRISPR Therapeutics AG stock?

* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.